Appendix 1 (Protocol for smoking cessation interventions)
Appendix 2 ('Stepped Care' approach in Scotland)
Appendix 3 (Membership of Expert Working Group)
Appendix 4 (Classification of tobacco use)
Appendix 5 (Estimated cost of making NRT available on prescription in Scotland)
Appendix 6 (Cost effectiveness of smoking cessation interventions)
Protocol for smoking cessation interventions
Agency for Health Care Policy and Research: protocols for smoking cessation interventions
The Agency for Health Care Policy Research in the USA has suggested a 'stepped care' approach to smoking cessation. This involves brief, low cost intervention for smokers who can stop without extensive support, moving up to provision of specialist smokers clinics for more dependent smokers. The AHCPR has recommended a set of protocols for maximising the effectiveness of smoking cessation interventions as follows:
Ref: Fiore MC, Bailey WC, Cohen SJ et. al. Smoking Cessation. Clinical Practice Guideline No.18. Rockville, MD: US Department of Health and Human Services Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 96-0692. April 1996
"Stepped Care" approach in Scotland
When discussing smoking cessation interventions it is important to consider which type of smoker the intervention is best targeted at, in terms of level of motivation to stop and degree of addiction to tobacco.
An effective stepped care approach could include the following components:
(Adapted from Foulds J. (1996) Strategies for smoking cessation. British Medical Bulletin; 52 (1) 157-173.)
Participants at ASH Scotland/HEBS Expert Working Group
Dr. Amanda Amos Senior Lecturer, Health Promotion
Public Health, Edinburgh University
Ms. Yvonne Bostock Consultant
Health & Health Research
Dr. Candace Currie Senior Research Fellow
Research Unit in Health & Behavioural Change
Ms. Sheila Duffy Information & Resource Development Manager
ASH Scotland
Ms. Sally Haw Research Specialist, Substance Misuse
Health Education Board for Scotland
Dr. James Inglis Consultant in Public Health Medicine
Health Education Board for Scotland
Ms. Irene Keltie Development Worker
Wester Hailes Health Project
Dr. Scott Lennox Clinical Research Fellow
Forresterhill Health Centre
Dr. John Logan Senior Registrar in Public Health Medicine
Health Education Board for Scotland
Mrs. Maureen Moore Chief Executive
ASH Scotland
Dr. Martin Raw Hon. Senior Lecturer in Public Health
King's College School of Medicine
Mrs. Wendy Ugolini Press & Campaigns Manager
ASH Scotland
OBSERVERS
Ms. Mary Cuthbert Smoking Action Manager
Drugs, Alcohol & Tobacco Policy Team, Scottish Office
Mr. Drew Peden Alcohol Action Manager
Drugs, Alcohol & Tobacco Policy Team, Scottish Office
ICD 10 classification of tobacco use
(ICD 10) categorises disorders that are attributable to the use of psychoactive substances. Category F17 covers Mental and behavioural disorders due to the use of tobacco. Three fourth-character subdivisions are relevant to tobacco use.
F17.1 Harmful use
A pattern of psychoactive substance use that is damaging to health. The damage may be physical or mental.
F17.2 Dependence syndrome
A cluster of behavioural, cognitive, and physiological phenomena that develop after repeated substance use and that typically include a strong desire to take the drug, difficulties in controlling its use, persisting in its use despite harmful consequences, a higher priority given to drug use than to other activities and obligations, increased tolerance, and sometimes a physical withdrawal state.
F17.3 Withdrawal state
A group of symptoms of variable clustering and severity occurring on absolute or relative withdrawal of a psychoactive substance after persistent use of that substance. The onset and course of the withdrawal state are time-limited and are related to the type of psychoactive substance and the dose being used immediately before cessation or reduction in use.
Estimated cost of making N. R. T. available on the NHS in Scotland
In Scotland 35% of adults smoke cigarettes, giving an adult smoking population of 1.4 million.
The NHS cost of NRT products (gum/patch) is estimated to be £8 per week, and a course is of three weeks duration, then the NHS cost of a completed course of NRT is £24.
Thirteen percent of smokers who attempt smoking cessation using NRT are successful. Therefore one in eight complete a successful course of NRT and 7 unsuccessful attempts are concluded after a weeks treatment. The estimated cost to the NHS is £80 per successful quitter.
The table below gives a range of estimates of the cost of providing NRT on the NHS based on the assumptions outlined above and three levels of demand per annum - 5%, 10% and 15% of adult smokers.
| Estimated Cost of Making Nicotine Replacement Therapy Available on the NHS | |||
| No of attempts at NRT | 5% Smokersn = 70,000 | 10% smokersn = 140,000 | 15% smokersn = 210,000 |
| Estimated cost per annum | £728,000 | £1,456,000 | £2,184,000 |
| Number of quitters per annum | 9,100 | 18,200 | 27,300 |
Cost effectiveness of smoking cessation interventions
| Cost per life year gained for the local NHS, smokers and both combined | |||
| NHS | SMOKERS | BOTH | |
| Primary health care interventions: | |||
| Brief advice | £81 | £13 | £94 |
| Additional cost per life on top of brief advice: | |||
| Brief counselling | £415 | £130 | £545 |
| Nicotine gum | £37 | £426 | £463 |
| Community interventions: | |||
| Local No Smoking Day activities | £21 | n.a. | £21 |
| Broader community wide campaigns with: | |||
| - 100% reach and 0.50% effectiveness | £54 | n.a. | £54 |
| - 100% reach and 0.10% effectiveness | £271 | n.a. | £271 |
| - 100% reach and 0.05% effectiveness | £541 | n.a. | £541 |
| Quit and Win competition with: | |||
| - average cost & participation | £522 | n.a. | £522 |
| - low cost & participation | £543 | n.a. | £543 |
| - high cost & participation | £711 | n.a. | £711 |
(Taken from Buck D, Godfrey C, Parrott S & Raw M. (1997) Cost effectiveness of smoking cessation interventions, HEA, London)